Zhong-Jie Yan
Overview
Explore the profile of Zhong-Jie Yan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
151
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Amniotic Mesenchymal Stem Cells Decrease Aβ Deposition and Improve Memory in APP/PS1 Transgenic Mice
Zheng X, Wan Q, Zheng C, Zhou H, Dong X, Deng Q, et al.
Neurochem Res
. 2017 Apr;
42(8):2191-2207.
PMID: 28397068
Transplantation of human amniotic mesenchymal stem cells (hAM-MSCs) seems to be a promising strategy for the treatment of neurodegenerative disorders, including Alzheimer's disease (AD). However, the clinical therapeutic effects of...
2.
Zhou H, Zhang X, Zhang M, Yan Z, Xu Z, Xu R
Neurochem Res
. 2016 Jun;
41(10):2708-2718.
PMID: 27351200
Human amniotic membrane mesenchymal stem cells (hAMSCs) are considered ideal candidate stem cells for cell-based therapy. In this study, we assessed whether hAMSCs transplantation promotes neurological functional recovery in rats...
3.
Yan Z, Hu Y, Zhang H, Zhang P, Xiao Z, Sun X, et al.
Cell Mol Neurobiol
. 2013 Mar;
33(4):465-75.
PMID: 23478940
Human mesenchymal stem cells (MSCs) are considered a promising tool for cell-based therapies of nervous system diseases. Bone marrow (BM) has been the traditional source of MSCs (BM-MSCs). However, there...
4.
Yan Z, Zhang P, Hu Y, Zhang H, Hong S, Zhou H, et al.
Neurochem Res
. 2013 Mar;
38(5):1022-33.
PMID: 23475428
Although human amnion derived mesenchymal stem cells (AMSC) are a promising source of stem cells, their therapeutic potential for traumatic brain injury (TBI) has not been widely investigated. In this...
5.
Sun X, Xu Z, Ke Y, Hu C, Wang S, Ling G, et al.
Cancer Lett
. 2011 Sep;
312(2):168-77.
PMID: 21924825
Immunotoxins have shown great promise as an alternative treatment for brain malignancies such as gliomas, but their failure to penetrate into the tumor mass remains a major problem. Mesenchymal stem...
6.
Xiao Z, Tang H, Xu Z, Yan Z, Li P, Cai Y, et al.
Cancer Biol Ther
. 2011 Apr;
11(11):974-80.
PMID: 21502808
Cancer stem cells are defined as a subpopulation of cancer cells with the capacity to self-renew and differentiate, which may play critical roles in tumor initiation, progress and resistance to...
7.
Li M, Zhang S, Guo Y, Cai Y, Yan Z, Zou Z, et al.
Neurochem Res
. 2010 Jul;
35(10):1522-9.
PMID: 20658188
Mesenchymal stem cells are capable of differentiating into dopaminergic-like cells, but currently no report has been available to describe the induction of human umbilical vein mesenchymal stem cells (HUVMSCs) into...
8.
Zhang H, Luo J, Sui L, Ma X, Yan Z, Lin J, et al.
Cell Mol Neurobiol
. 2009 Jun;
29(8):1283-92.
PMID: 19533335
Controversies exist concerning the need for mesenchymal stromal cells (MSCs) to be transdifferentiated prior to their transplantation. In the present study, we compared the results of grafting into the rat...
9.
Zhang H, Cheng H, Cai Y, Ma X, Liu W, Yan Z, et al.
Neurosci Lett
. 2009 Apr;
458(3):116-21.
PMID: 19394407
This study is designed to evaluate the therapeutic effects of three types of neurospheres (NSs) derived from brain, bone marrow and adipose tissue in a rat model of spinal contusive...